http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010126828-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34 |
| filingDate | 2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010126828-A |
| titleOfInvention | MORPHOLINE DERIVATIVES AS AN OBESITY MEANS |
| abstract | 1. The compound of formula (I) !! or a pharmaceutically acceptable salt, solvate, hydrate, geometric isomer, tautomer, optical isomer or N-oxide thereof, where! A is selected from! where X1 represents N or CH; ! and! where X2 represents N (R1), CH (R2) or O; ! R1 is selected from hydrogen, C1-6 alkyl (unsubstituted or optionally substituted with one or more substituents independently selected from halogen, hydroxy, cyano and C1-6 alkoxy) and C1-6 acyl (unsubstituted or optionally substituted with one or more substituents independently selected from halogen, hydroxy and C1-6-alkoxy), phenyl and benzyl (unsubstituted or optionally substituted with one or more substituents independently selected from halogen, hydroxy, cyano, nitro, CF3, C1-6-alkyl and C1-6 alkoxy); ! R2 and R3 are independently selected from hydrogen, halogen, hydroxy, C1-6 alkyl (unsubstituted or optionally substituted with one or more substituents independently selected from halogen, hydroxy and C1-6 alkoxy) and C1-6 alkoxy (unsubstituted or optionally substituted by one or more substituents independently selected from halogen, hydroxy and C1-6 alkoxy); ! Y represents CH2, O or N (R4); ! R4 is hydrogen or C1-4 alkyl; ! each of a and b is independently 1, 2 or 3; ! each of c and d is independently 0, 1 or 2; and! e is 1, 2 or 3; ! provided that the compound is not selected from the group consisting of:! - 2- (4-piperidinyl) ethyl- (2R, 6S) -2,6-dimethylmorpholin-4-carboxylate; ! - N- (4-piperidinyl methyl) -4-morpholinecarboxamide; ! - 4- [1-oxo-3- (4-piperidinyl) propyl] morpholine; ! - 4- [1-oxo-3- (1-piperazinyl) propyl] morpholine; ! - 4- [3- [4- (4-chlorophenyl) -1-piperazinyl] -1-oxoaprpyl] morpholine; ! - N- [3- (1-piperazinyl) propyl] -4-morpholinecarboxamide; ! - 2-morpholinylmethyl 2- (hydr |
| priorityDate | 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.